[ Price : $8.95]
Pliant Therapeutics pauses enrollment and dosing due to an undisclosed safety concern in its ongoing BEACON-IPF Phase 2b trial of ...[ Price : $8.95]
FDA posts a final guidance entitled Institutional Review Board (IRB) Written Procedures that is intended to harmonize FDA and HHS ...[ Price : $8.95]
Boehringer Ingelheim plans to submit an NDA for nerandomilast for treating progressive pulmonary fibrosis following its release of...[ Price : $8.95]
FDA clears an Ibex Medical Analytics 510(k) for the Ibex Prostate Detect, an in vitro diagnostic that uses artificial intelligence...[ Price : $8.95]
FDA grants Tempest Therapeutics a fast track designation for amezalpat (TPST-1120) for treating patients with hepatocellular carci...[ Price : $8.95]
Roche shares with FDA positive data from the Phase 3 REGENCY trial of Gazyva (obinutuzumab) in people with active lupus nephritis.[ Price : $8.95]
Senators Dick Durbin (D-IL) and Roger Marshall (R-KS) call on FDA to take enforcement action against a planned direct-to-consumer ...[ Price : $8.95]
FDA clears a RapidAI 510(k) for its Lumina 3D, an automated 3D imaging reconstruction device designed to replace manual workflows.